ÂÜÀòÂÒÂ×

Dr. Linda Friedland is a distinguished medical professional with extensive experience in various leadership and advisory roles. Currently serving as Deputy Chair at the Neurological Council of Western Australia since January 2014, Dr. Friedland also holds positions as Advisor & Consultant at The Healing Company, Australia & Asia Pacific Partner at Camelot BioCapital, Medical Consultant at Firebrick Pharma, and Senior Consultant at TargImmune Therapeutics AG. Additionally, Dr. Friedland is a Director at FFD Capital LLC and has previously acted as Chief Medical Officer at The Anti-inflammaging Company and Patron of the Lymphangiomyomatosis Research Alliance. A graduate of the University of the Witwatersrand with an MBBCh in Medicine, Dr. Friedland also completed the GAICD program at the Australian Institute of Company Directors.